Valeant Pharmaceuticals Acquires Ambi Skin Care

Skin care brand Ambi is transitioning from one parent company to another. Johnson & Johnson has sold the Ambi brand to Valeant Pharmaceuticals North America. Valeant is a multinational, 17 billion market cap pharmaceutical/OTC company based in Bridgewater, New Jersey. It also owns beauty brand Kinerase, AcneFree, CeraVe and more, in addition to multiple derm brands and other pharmaceutical product brands.

More in News